Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer
Authors
Keywords
-
Journal
Nature Communications
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-02-10
DOI
10.1038/s41467-022-28421-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The clinical relevance of gene expression based prognostic signatures in colorectal cancer
- (2021) Pankaj Ahluwalia et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Identification of LncRNAs Associated With FOLFOX Chemoresistance in mCRC and Construction of a Predictive Model
- (2021) Yiyi Zhang et al. Frontiers in Cell and Developmental Biology
- Prognostic Cancer Gene Expression Signatures: Current Status and Challenges
- (2021) Yuquan Qian et al. Cells
- Genomic Alteration Characterization in Colorectal Cancer Identifies a Prognostic and Metastasis Biomarker: FAM83A|IDO1
- (2021) Zaoqu Liu et al. Frontiers in Oncology
- Establishment and experimental validation of an immune miRNA signature for assessing prognosis and immune landscape of patients with colorectal cancer
- (2021) Zaoqu Liu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Hypoxia induced LUCAT1/PTBP1 axis modulates cancer cell viability and chemotherapy response
- (2020) Lin Huan et al. Molecular Cancer
- Prognostic and Predictive Molecular Biomarkers for Colorectal Cancer: Updates and Challenges
- (2020) Koncina et al. Cancers
- Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook
- (2020) Josep Garcia et al. CANCER TREATMENT REVIEWS
- Pembrolizumab in MSI-H–dMMR Advanced Colorectal Cancer — A New Standard of Care
- (2020) Axel Grothey NEW ENGLAND JOURNAL OF MEDICINE
- Identification of an Immune-Related Gene Signature to Improve Prognosis Prediction in Colorectal Cancer Patients
- (2020) Siqi Dai et al. Frontiers in Genetics
- Emerging Role and Therapeutic Potential of lncRNAs in Colorectal Cancer
- (2020) Laura Schwarzmueller et al. Cancers
- Immunotherapy in colorectal cancer: rationale, challenges and potential
- (2019) Karuna Ganesh et al. Nature Reviews Gastroenterology & Hepatology
- Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis
- (2019) Linbo Chen et al. GENE
- Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer
- (2019) R Dienstmann et al. ANNALS OF ONCOLOGY
- 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future
- (2019) Sona Vodenkova et al. PHARMACOLOGY & THERAPEUTICS
- AJCC 8th Edition: Colorectal Cancer
- (2018) Martin R. Weiser ANNALS OF SURGICAL ONCOLOGY
- Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
- (2018) Michael J. Overman et al. JOURNAL OF CLINICAL ONCOLOGY
- Long Noncoding RNA in Cancer: Wiring Signaling Circuitry
- (2018) Chunru Lin et al. TRENDS IN CELL BIOLOGY
- Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
- (2018) T A Chan et al. ANNALS OF ONCOLOGY
- A molecular portrait of microsatellite instability across multiple cancers
- (2017) Isidro Cortes-Ciriano et al. Nature Communications
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
- (2017) Pornpimol Charoentong et al. Cell Reports
- Predictive biomarkers for checkpoint inhibitor-based immunotherapy
- (2016) Geoffrey T Gibney et al. LANCET ONCOLOGY
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- Colon cancer subtypes: concordance, effect on survival and selection of the most representative preclinical models
- (2016) Zsófia Sztupinszki et al. Scientific Reports
- The consensus molecular subtypes of colorectal cancer
- (2015) Justin Guinney et al. NATURE MEDICINE
- Combination cancer immunotherapy and new immunomodulatory targets
- (2015) Kathleen M. Mahoney et al. NATURE REVIEWS DRUG DISCOVERY
- New Approaches but the Same Flaws in the Search for Prognostic Signatures
- (2014) R. Salazar et al. CLINICAL CANCER RESEARCH
- Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value
- (2013) Laetitia Marisa et al. PLOS MEDICINE
- Prognostic and Predictive Markers in Stage II Colon Cancer: Is There a Role for Gene Expression Profiling?
- (2011) Robin K. Kelley et al. Clinical Colorectal Cancer
- ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
- (2010) Matthew D. Wilkerson et al. BIOINFORMATICS
- SeqMap: mapping massive amount of oligonucleotides to the genome
- (2008) H. Jiang et al. BIOINFORMATICS
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
- (2008) Leonard B. Saltz et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More